Skip to main content

Closed

ALLO: Allogene Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-50.6%

Financially safe

Stretched

Debt / equity0.29×

Interest coverage-155.3×

Current ratio9.65×

Allogene Therapeutics, Inc.

ALLONASDAQ Global Select·USD·Closed

Allogene Therapeutics, Inc.

ALLONASDAQ·USD·Closed

$1.88

−4.57%

$1.88

−$0.09 (4.57%)

52W Range

26thpctl

Volume

0.67×avg

Mkt Cap

648.89MUSD

P/E

-2.6TTM

Div Yield

–ann

52W Range

26thpctl

Volume

0.67×avg

Market Cap

648.89MUSD

P/E Ratio

-2.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings